GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
115 hedge funds and large institutions have $57M invested in Sanofi Contingent Value Rights in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
15% less capital invested
Capital invested by funds: $67.2M → $57M (-$10.1M)
Holders
115
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.38M | |
| 2 | +$209K | |
| 3 | +$171K | |
| 4 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$105K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$100K |
Top Sellers
| 1 | -$3.29M | |
| 2 | -$6K | |
| 3 | -$5.24K | |
| 4 |
EWM
Edge Wealth Management
New York
|
-$1K |
| 5 |
BWM
Baystate Wealth Management
Boston,
Massachusetts
|
-$1K |